Rallybio Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Rallybio Corp
RLYB Stock  USD 0.66  0.02  3.59%   
Rallybio Corp's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Rallybio Corp's valuation are provided below:
Gross Profit
-38.4 M
Market Capitalization
27.1 M
Revenue
674 K
Earnings Share
(0.32)
Quarterly Revenue Growth
(0.29)
We have found one hundred twenty available trending fundamental ratios for Rallybio Corp, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to check out all of Rallybio Corp recent market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. As of February 2, 2026, Market Cap is expected to decline to about 105.6 M. In addition to that, Enterprise Value is expected to decline to about 79.3 M

Rallybio Corp Total Revenue

767,970

Check Rallybio Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rallybio Corp's main balance sheet or income statement drivers, such as Tax Provision of 1.2 K, Net Interest Income of 5.1 M or Interest Income of 5.1 M, as well as many indicators such as Price To Sales Ratio of 52.58, Dividend Yield of 0.0 or PTB Ratio of 0.74. Rallybio financial statements analysis is a perfect complement when working with Rallybio Corp Valuation or Volatility modules.
  
Build AI portfolio with Rallybio Stock
Check out the analysis of Rallybio Corp Correlation against competitors.
For information on how to trade Rallybio Stock refer to our How to Trade Rallybio Stock guide.

Rallybio Corp Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets130.1 M78.3 M65.5 M
Slightly volatile
Other Current Liabilities6.5 M5.7 M4.4 M
Slightly volatile
Total Current Liabilities7.8 M7.2 M5.4 M
Slightly volatile
Total Stockholder Equity122 M70.9 M59.4 M
Slightly volatile
Other Liabilities27.4 K28.8 K565.1 K
Slightly volatile
Property Plant And Equipment Net506.9 K307.1 K315.9 K
Slightly volatile
Accounts Payable237.7 K250.2 K800.5 K
Slightly volatile
Cash11.9 M12.5 M37.1 M
Pretty Stable
Non Current Assets Total228.3 K240.3 K664 K
Slightly volatile
Cash And Short Term Investments124.6 M75.3 M62 M
Slightly volatile
Common Stock Shares Outstanding35.3 M50.1 M28.1 M
Slightly volatile
Liabilities And Stockholders Equity130.1 M78.3 M65.5 M
Slightly volatile
Non Current Liabilities Total232.5 K190.8 K625.7 K
Slightly volatile
Other Current Assets4.7 M2.7 M2.7 M
Slightly volatile
Total Liabilities8.1 M7.4 M6 M
Slightly volatile
Property Plant And Equipment Gross828.9 K1.1 M482.4 K
Slightly volatile
Total Current Assets129.3 M78 M64.8 M
Slightly volatile
Net Working Capital121.5 M70.8 M59.4 M
Slightly volatile
Common Stock3.4 K3.6 K136.7 K
Slightly volatile
Property Plant Equipment380.1 K442.8 K280.3 K
Slightly volatile
Capital Stock3.7 K4.6 K2.7 K
Slightly volatile
Non Currrent Assets Other286.4 K215.1 K627.6 K
Slightly volatile
Common Stock Total Equity3.9 K4.6 K3.3 K
Slightly volatile
Capital Surpluse329.9 M379.7 M290.3 M
Slightly volatile
Short and Long Term Debt Total131.7 K138.6 K472.4 K
Slightly volatile
Short Term Debt147.7 K138.6 K177.2 K
Slightly volatile
Current Deferred Revenue678.4 K763.2 K833 K
Slightly volatile

Rallybio Corp Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Interest Income5.1 M4.8 M1.4 M
Slightly volatile
Interest Income5.1 M4.8 M1.4 M
Slightly volatile
Depreciation And Amortization118.3 K150.7 K67.7 K
Slightly volatile
Interest Expense2.8 M2.7 M752.8 K
Slightly volatile
Selling General Administrative19.2 M22.6 M12 M
Slightly volatile
Other Operating Expenses54.4 M70.3 M34.1 M
Slightly volatile
Research Development35.1 M47.7 M22.2 M
Slightly volatile
Cost Of Revenue118.3 K150.7 K67.7 K
Slightly volatile
Total Operating Expenses54.4 M70.3 M34.1 M
Slightly volatile
Reconciled Depreciation118.8 K150.7 K67.7 K
Slightly volatile
Selling And Marketing Expenses20.3 M22.8 M24.9 M
Slightly volatile

Rallybio Corp Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation6 M9.2 M2.9 M
Slightly volatile
Begin Period Cash Flow26.8 M28.2 M29.6 M
Slightly volatile
Depreciation118.2 K150.7 K67.5 K
Slightly volatile
Total Cash From Financing Activities4.4 M4.7 M35.8 M
Very volatile
End Period Cash Flow11.9 M12.5 M37.1 M
Pretty Stable
Change To Netincome12.8 M12.2 M3.9 M
Slightly volatile
Change To Liabilities4.5 M4.3 M1.7 M
Slightly volatile
Sale Purchase Of Stock53 K55.8 K58.6 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio52.5859.1664.5685
Slightly volatile
PTB Ratio0.740.7811.437
Slightly volatile
Book Value Per Share1.551.631.8647
Slightly volatile
Stock Based Compensation To Revenue10.0611.3112.3461
Slightly volatile
Capex To Depreciation0.08740.0924.6021
Slightly volatile
PB Ratio0.740.7811.437
Slightly volatile
EV To Sales35.2939.743.3321
Slightly volatile
Payables Turnover0.02460.02770.0302
Slightly volatile
Sales General And Administrative To Revenue24.6927.7730.3126
Slightly volatile
Research And Ddevelopement To Revenue52.2158.7464.1111
Slightly volatile
Cash Per Share1.641.731.9654
Slightly volatile
Days Payables Outstanding9.5 K10.7 K11.7 K
Slightly volatile
Income Quality0.950.980.8711
Slightly volatile
Net Debt To EBITDA0.250.261.3224
Very volatile
Current Ratio17.8312.510.4146
Slightly volatile
Tangible Book Value Per Share1.551.631.8647
Slightly volatile
Shareholders Equity Per Share1.551.631.8647
Slightly volatile
Debt To Equity0.00350.00290.0032
Pretty Stable
Capex Per Share3.0E-43.0E-40.0061
Slightly volatile
Graham Net Net1.481.561.7499
Slightly volatile
Revenue Per Share0.01170.01310.0143
Slightly volatile
Interest Debt Per Share0.00470.00320.0034
Slightly volatile
Debt To Assets0.00320.00260.003
Slightly volatile
Price Book Value Ratio0.740.7811.437
Slightly volatile
Days Of Payables Outstanding9.5 K10.7 K11.7 K
Slightly volatile
Ebt Per Ebit1.091.11.0035
Slightly volatile
Effective Tax Rate0.0150.01430.0058
Slightly volatile
Company Equity Multiplier1.211.271.2138
Slightly volatile
Total Debt To Capitalization0.00350.00290.0032
Pretty Stable
Debt Equity Ratio0.00350.00290.0032
Pretty Stable
Quick Ratio17.8312.510.4146
Slightly volatile
Net Income Per E B T1.11.131.0154
Slightly volatile
Cash Ratio2.432.566.8854
Very volatile
Free Cash Flow Operating Cash Flow Ratio1.111.151.0235
Slightly volatile
Price To Book Ratio0.740.7811.437
Slightly volatile
Fixed Asset Turnover1.92.142.3394
Slightly volatile
Debt Ratio0.00320.00260.003
Slightly volatile
Price Sales Ratio52.5859.1664.5685
Slightly volatile
Asset Turnover0.00750.00840.0092
Slightly volatile
Price Fair Value0.740.7811.437
Slightly volatile

Rallybio Corp Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap105.6 M111.2 M257.4 M
Slightly volatile
Enterprise Value79.3 M83.5 M218.1 M
Slightly volatile

Rallybio Fundamental Market Drivers

Rallybio Upcoming Events

4th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Rallybio Corp Financial Statements

Rallybio Corp stakeholders use historical fundamental indicators, such as Rallybio Corp's revenue or net income, to determine how well the company is positioned to perform in the future. Although Rallybio Corp investors may analyze each financial statement separately, they are all interrelated. For example, changes in Rallybio Corp's assets and liabilities are reflected in the revenues and expenses on Rallybio Corp's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Rallybio Corp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue763.2 K678.4 K
Total Revenue731.4 K768 K
Cost Of Revenue150.7 K118.3 K
Stock Based Compensation To Revenue 11.31  10.06 
Sales General And Administrative To Revenue 27.77  24.69 
Research And Ddevelopement To Revenue 58.74  52.21 
Revenue Per Share 0.01  0.01 
Ebit Per Revenue(85.61)(89.89)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VGIAXVanguard Growth And
XARSPDR SP Aerospace
XARSPDR SP Aerospace
When determining whether Rallybio Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Rallybio Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Rallybio Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Rallybio Corp Stock:
How To Invest In Rallybio
Details
Is Rallybio Stock a good investment?
Details
What is Rallybio Corp's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Rallybio Corp Correlation against competitors.
For information on how to trade Rallybio Stock refer to our How to Trade Rallybio Stock guide.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rallybio Corp. Anticipated expansion of Rallybio directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Rallybio Corp assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(0.32)
Revenue Per Share
0.015
Quarterly Revenue Growth
(0.29)
Return On Assets
(0.28)
Return On Equity
(0.21)
The market value of Rallybio Corp is measured differently than its book value, which is the value of Rallybio that is recorded on the company's balance sheet. Investors also form their own opinion of Rallybio Corp's value that differs from its market value or its book value, called intrinsic value, which is Rallybio Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rallybio Corp's market value can be influenced by many factors that don't directly affect Rallybio Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
It's important to distinguish between Rallybio Corp's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Rallybio Corp should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Rallybio Corp's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY